Invokana, Farxiga, Jardiance Get Ketoacidosis, Urinary Tract Infection Warnings
SILVER SPRING, Md. — The Food and Drug Administration on Dec. 4 said a safety review of sodium-glucose cotransporter-2 (SGLT2) inhibitors has resulted in new label warnings about the risk of...To view the full article, register now.
Already a subscriber? Click here to view full article